CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failure

Những quyển sách tương tự

• Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival
  Bằng: Johnson, Nathalie A., et al.
  Được phát hành: (2009)
• Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas
  Bằng: Kansara, Roopesh, et al.
  Được phát hành: (2016)
• Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP
  Bằng: Shustik, Jesse, et al.
  Được phát hành: (2010)
• Genetic polymorphism at BCL2 as a predictor for rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone efficacy in patients with diffuse large B-cell lymphoma
  Bằng: Bashash, Morteza, et al.
  Được phát hành: (2017)
• Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP
  Bằng: Malumbres, Raquel, et al.
  Được phát hành: (2008)